Session Details
[S07]Division of Pharma-Biology Symposium: Diversity Microbiology Research Seed Creation and Strategy
Thu. Mar 27, 2025 1:15 PM - 2:45 PM JST
Thu. Mar 27, 2025 4:15 AM - 5:45 AM UTC
Thu. Mar 27, 2025 4:15 AM - 5:45 AM UTC
Room 7 (Fukuoka International Congress Center: 204 [2F])
Organizer: Juntaro Matsuzaki (Fac. Pharm., Keio Univ.), Akiko Takaya (Infect. Cont. Sci., Grad. Sch. Pharm. Sci., Chiba Univ. / MMRC, Chiba Univ.)
Microbiological research targets not only infectious diseases but also immunological and allergic diseases, lifestyle-related diseases, cancer, and other extremely diverse diseases. Analytical methods also require a high level of expertise in handling big data, owing to advances in various omics analysis technologies, and cross-disciplinary research collaboration is becoming increasingly important. This symposium aims to provide a starting point for the creation of new seeds for drug discovery research by sharing the latest knowledge on how microbiology research is conducted by researchers from various backgrounds and specialties. Through lectures by top-runner speakers, we hope that the symposium will provide a valuable opportunity for participants to deepen their understanding of how to approach research, analytical methods and ideas, and diverse interactions between hosts and bacteria, and to consider the possibility of new drug discovery targets.
オーガナイザー挨拶:松崎 潤太朗(慶應大薬)
[S07-1]The diet-microbiota axis consolidates mucosal IgA response by inducing T follicular helper cells in Peyer’s patches
○Daisuke Takahashi1, Kisara Hattori1, Koji Hase1 (1. Fac. Pharm., Keio Univ.)
[S07-2]Pathogenic relationship between endometriosis and related bacteria
○Ayako Muraoka1, Akira Yokoi1, Kosuke Yoshida1, Masami Kitagawa1, Natsuki Miyake1, Reina Sonehara1, Tomoko Nakamura1, Satoko Osuka1, Hiroaki Kajiyama1 (1. Nagoya Univ. Hosp.)
[S07-3]The role of bacterial extracellular vesicles in disease pathogenesis
○Hitoshi Tsugawa1 (1. Sch. Med., TOKAI Univ.)
[S07-4]Analysis of host cell factors involved in bacterial toxins using genome editing technologies
○Toshiyuki Yamaji1,2, Yuta Homma1,2 (1. Fac. Pharm., Juntendo Univ, 2. NIID)
[S07-5]Next-generation antimicrobials to combat drug-resistant bacterial infections
○Akiko Takaya1,2 (1. Infect. Cont. Sci., Grad. Sch. Pharm. Sci., Chiba Univ., 2. MMRC, Chiba Univ.)